Protai
PrivateLast Round
Seed
Mar 15, 2023
Total Funding Raised
$20M
Company Overview
Protai is a biotechnology company that has developed an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protai Comps
Public and private peers based on sector, stage, and business model.
Protai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 15, 2023 | ||||
| Seed | Jan 5, 2022 |
Key People
Founding team and executive leadership
Protai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity Fund | Seed |
| Grove Ventures | Seed |
| Pitango HealthTech | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
Attending ACR Convergence 2025 to expand into Immunology & Inflammation.
Protai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Protai's valuation, stock price, and market status.
